Abstract

Physical and biochemical aspects of protein crystal nucleation can be distinguished in an appropriately designed experimental setting. From a physical perspective, the diminishing number of nucleation-active particles (and/or centers), and the appearance of nucleation exclusion zones, are two factors that act simultaneously and retard the initially fast heterogeneous nucleation, thus leading to a logistic time dependence of nuclei number density. Experimental data for protein crystal (and small-molecule droplet) nucleation are interpreted on this basis. Homogeneous nucleation considered from the same physical perspective reveals a difference—the nucleation exclusion zones lose significance as a nucleation decelerating factor when their overlapping starts. From that point on, a drop of overall system supersaturation becomes the sole decelerating factor. Despite the different scenarios of both heterogeneous and homogeneous nucleation, S-shaped time dependences of nuclei number densities are practically indistinguishable due to the exponential functions involved. The biochemically conditioned constraints imposed on the protein crystal nucleation are elucidated as well. They arise because of the highly inhomogeneous (patchy) protein molecule surface, which makes bond selection a requisite for protein crystal nucleation (and growth). Relatively simple experiments confirm this assumption.

Highlights

  • Biomolecule structures are essential when it comes to understanding the mechanisms of life and human genomes, and developing novel protein-based pharmaceuticals

  • classical nucleation theory (CNT) limitations limitations should rest upon interpretation of some basic experimental observations

  • Insulin crystal nucleation kinetics was studied via the so-called nucleation and growth separation principle

Read more

Summary

Introduction

Biomolecule structures are essential when it comes to understanding the mechanisms of life and human genomes, and developing novel protein-based pharmaceuticals. The most powerful method for structure-function studies of biomolecules is X-ray diffraction (with complementary neutron diffraction) and Nuclear Magnetic Resonance, considered as an ancillary tool only. Both X-ray and neutron diffraction require well-diffracting crystals [1]. Growing such crystals of newly-expressed proteins is, the major obstacle in protein structure determination. There is no recipe for their growth. It is usually the trial-and-error approach that is applied. Despite the numerous state-of-the-art crystallization tools employed (such as robots, automation and miniaturization of crystallization trials, Dynamic Light Scattering, crystallization screening kits, etc.), researchers’ creativeness and acumen remain indispensable

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call